Revolution of Therapy in Acute Lymphoblastic Leukemia

home / peer-exchange / therapy-revolution-all
Molecular Cytogenetic Risk Stratification in ALL

EP. 1: Molecular Cytogenetic Risk Stratification in ALL

January 22nd 2019
Pediatric-Inspired Regimens in ALL

EP. 2: Pediatric-Inspired Regimens in ALL

January 22nd 2019
How Age Affects Treatment Approaches in ALL

EP. 3: How Age Affects Treatment Approaches in ALL

January 22nd 2019
Effective Novel Agents in Upfront Treatment of ALL

EP. 4: Effective Novel Agents in Upfront Treatment of ALL

January 22nd 2019
Considerations of Cytoreduction in ALL

EP. 5: Considerations of Cytoreduction in ALL

January 22nd 2019
Revolutionizing the Treatment of Ph+ ALL with TKIs

EP. 6: Revolutionizing the Treatment of Ph+ ALL with TKIs

January 22nd 2019
Therapeutic Approaches in Philadelphia-like ALL

EP. 7: Therapeutic Approaches in Philadelphia-like ALL

January 22nd 2019
Role of MRD Testing in Adult Acute Lymphocytic Leukemia

EP. 8: Role of MRD Testing in Adult Acute Lymphocytic Leukemia

January 22nd 2019

EP. 9: Time Points in the Assessment of MRD

January 22nd 2019
Monitoring for Relapse in Acute Lymphoblastic Leukemia

EP. 10: Monitoring for Relapse in Acute Lymphoblastic Leukemia

January 22nd 2019
Blinatumomab for Patients with MRD-Positive ALL

EP. 11: Blinatumomab for Patients with MRD-Positive ALL

January 22nd 2019
The Evolving Role of Transplant in ALL

EP. 12: The Evolving Role of Transplant in ALL

January 22nd 2019

EP. 13: CAR T: Dominant Therapy for B-Cell ALL

January 22nd 2019
Examining the Toxicities of CAR T-cell Therapy

EP. 14: Examining the Toxicities of CAR T-cell Therapy

January 22nd 2019
Acute Lymphocytic Leukemia: What's Next

EP. 15: Acute Lymphocytic Leukemia: What's Next

January 22nd 2019
Approaching the Management of Philadelphia-Negative ALL

EP. 16: Approaching the Management of Philadelphia-Negative ALL

January 22nd 2019
Treatment Algorithms for Philadelphia-Negative ALL

EP. 17: Treatment Algorithms for Philadelphia-Negative ALL

January 22nd 2019
Ph-Negative ALL: Establishing Blinatumomab's Role in Therapy

EP. 18: Ph-Negative ALL: Establishing Blinatumomab's Role in Therapy

January 22nd 2019
Blinatumomab: Safety Data in Ph-Negative ALL

EP. 19: Blinatumomab: Safety Data in Ph-Negative ALL

January 22nd 2019
Establishing MRD's Role in ALL Management

EP. 20: Establishing MRD's Role in ALL Management

January 22nd 2019
Allogeneic Transplant at First Remission of ALL

EP. 21: Allogeneic Transplant at First Remission of ALL

January 22nd 2019
Selecting a Novel Therapy for Relapsed/Refractory ALL

EP. 22: Selecting a Novel Therapy for Relapsed/Refractory ALL

January 22nd 2019
When to Use Inotuzumab Ozogamicin for Adult ALL

EP. 23: When to Use Inotuzumab Ozogamicin for Adult ALL

January 22nd 2019
Evaluating CAR T Therapy in Acute Lymphoblastic Leukemia

EP. 24: Evaluating CAR T Therapy in Acute Lymphoblastic Leukemia

January 22nd 2019
Future Treatment Strategies in Adult ALL

EP. 25: Future Treatment Strategies in Adult ALL

January 22nd 2019